enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
9.87
+0.34 (3.57%)
Feb 11, 2026, 2:15 PM EST - Market open
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $661.14 million as of February 11, 2026. Its market cap has increased by 91.57% in one year.
Market Cap
661.14M
Enterprise Value
485.13M
1-Year Change
91.57%
Ranking
Category
Stock Price
$9.87
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $661.14M, an increase of 324.05%. That is a compound annual growth rate of 43.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 638.36M | 5.54% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 698.87M |
| Kura Oncology | 676.13M |
| Fulcrum Therapeutics | 674.88M |
| Jade Biosciences | 665.68M |
| Alpha Tau Medical | 657.39M |
| SELLAS Life Sciences Group | 648.77M |
| Replimune Group | 642.00M |
| Prime Medicine | 635.57M |